Butyphthalide to improve thinking after a recent stroke
Part of Brain & nervous system, Heart & circulation clinical trials.
This Phase 3 study tests whether butyphthalide can help thinking and memory improve after an acute ischemic stroke. It compares people who take the study medicine versus usual care, and measures cognitive (thinking) changes over follow-up.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You had an ischemic stroke within the last 14 days (confirmed by CT or MRI).
- You are age 60 or older.
- Your stroke severity score (NIHSS) is between 3 and 18.
- You can do study visits, questionnaires, physical exams, and brain MRI testing.
- You (or your legally authorized representative) agree by signing the consent form.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests an investigational drug called Dimephosphon to see if it helps people recover from a recent ischemic stroke (a stroke caused by a clot). It is for adults ages 35–80 whose symptoms began 24 to 72 hours ago and who have not received clot-busting treatments.
This trial tests if butylphthalide, a medicine given by mouth, can help prevent long-term thinking and memory problems after a minor stroke. It is for people who had a very mild stroke and enrolled soon after.
This trial tests whether a medication called butylphthalide can help reduce brain swelling that sometimes occurs after emergency endovascular treatment (a minimally invasive procedure to restore blood flow) for certain types of stroke.
This trial tests if butylphthalide, a drug that may improve blood flow, helps people with a narrowed artery in the brain (the middle cerebral artery) after a recent stroke or mini-stroke. It is for people aged 55-75 with at least one risk factor like high blood pressure or diabetes.
This study tests whether a medicine called butylphthalide can help improve memory and thinking in older adults with focal epilepsy who already have mild cognitive issues. It aims to find a new way to support brain health in people with epilepsy.
This trial tests a medicine called butylphthalide (a brain-protecting drug) to see if it can help with memory and thinking problems that some people have after chemotherapy. It is for people who received paclitaxel or platinum chemo and are now cancer-free but still struggling with 'chemo brain' symptoms like forgetfulness.
Hear when a new Stroke trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.